Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

P-450 Eicosanoids: A Novel Signaling Pathway Regulating Renal Function.

Richard J. Roman1, Magdalena Alonso-Galicia

  • 1Department of Physiology, Medical College of Wisconsin, Milwaukee, WI 53226.

News in Physiological Sciences : an International Journal of Physiology Produced Jointly by the International Union of Physiological Sciences and the American Physiological Society
|June 8, 2001
PubMed
Summary

Cytochrome P-450 enzymes metabolize arachidonic acid into epoxyeicosatrienoic acids (EETs) and 20-hydroxyeicosatetraenoic acid (20-HETE) in the kidney, regulating vascular tone and sodium reabsorption.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffold.

Bioorganic & medicinal chemistry letters·2016
Same author

Discovery of MK-7145, an Oral Small Molecule ROMK Inhibitor for the Treatment of Hypertension and Heart Failure.

ACS medicinal chemistry letters·2016
Same author

The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter's Syndrome Type II Phenotype.

The Journal of pharmacology and experimental therapeutics·2016
Same author

Differentiation of ROMK potency from hERG potency in the phenacetyl piperazine series through heterocycle incorporation.

Bioorganic & medicinal chemistry letters·2016
Same author

Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation.

ACS medicinal chemistry letters·2015
Same author

Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism Diuretics.

ACS medicinal chemistry letters·2014

Area of Science:

  • Nephrology
  • Biochemistry
  • Physiology

Background:

  • Cytochrome P-450 enzymes are crucial for metabolizing arachidonic acid in the kidney.
  • Epoxyeicosatrienoic acids (EETs) and 20-hydroxyeicosatetraenoic acid (20-HETE) are key metabolites with significant physiological roles.

Purpose of the Study:

  • To elucidate the role of Cytochrome P-450 metabolites in renal function.
  • To understand the mechanisms regulating renal vascular tone and sodium reabsorption.

Main Methods:

  • Metabolomic analysis of kidney tissue.
  • Enzymatic assays to determine P-450 activity.
  • Physiological studies on renal vascular tone and ion transport.

Main Results:

Related Experiment Videos

  • Identified specific Cytochrome P-450 isoforms responsible for arachidonic acid metabolism in the kidney.
  • Demonstrated the involvement of EETs and 20-HETE as critical second messengers.
  • Showcased the regulatory impact of these metabolites on renal vascular tone and sodium handling.

    • Conclusions:

    • Cytochrome P-450-derived metabolites, EETs and 20-HETE, are vital regulators of kidney function.
    • These compounds play a central role in maintaining renal homeostasis through vascular tone modulation and sodium reabsorption control.